These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 3228092)

  • 1. Accuracy of delivery of cefazolin, chloramphenicol, and vancomycin by a controlled-release membrane infusion device.
    Nahata MC; Durrell DE; Miller MA
    Am J Hosp Pharm; 1988 Nov; 45(11):2358-60. PubMed ID: 3228092
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of primary fluids and dilutional volumes on the delivery of cefazolin sodium by a membrane infusion device.
    Nahata MC; Durrell DE; Miller MA
    Am J Hosp Pharm; 1989 Nov; 46(11):2318-21. PubMed ID: 2589351
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Penetration of moxalactam and cefazolin into bone following simultaneous bolus or infusion.
    Polk R; Hume A; Kline BJ; Cardea J
    Clin Orthop Relat Res; 1983; (177):216-21. PubMed ID: 6222858
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Temperature of refrigerated i.v. fluids and admixtures during infusion.
    Stiles ML; Mickschl D; Thompson DF
    Am J Hosp Pharm; 1989 May; 46(5):977-9. PubMed ID: 2499192
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An analysis of drug delivery dynamics via a pediatric central venous infusion system: quantification of delays in achieving intended doses.
    Bartels K; Moss DR; Peterfreund RA
    Anesth Analg; 2009 Oct; 109(4):1156-61. PubMed ID: 19762743
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of an extension set for intermittent intravenous drug delivery to infants.
    Leff RD; Johnson GF; Erenberg A; Roberts RJ
    Am J Hosp Pharm; 1985 Jun; 42(6):1358-62. PubMed ID: 4014253
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Factors affecting drug delivery from a syringe-pump infusion set.
    Geater RE; Leff RD; Roberts RJ
    Am J Hosp Pharm; 1985 Nov; 42(11):2510-3. PubMed ID: 4073070
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stability of vancomycin hydrochloride in 5% dextrose and 0.9% sodium chloride injections.
    Das Gupta V; Stewart KR; Nohria S
    Am J Hosp Pharm; 1986 Jul; 43(7):1729-31. PubMed ID: 3752110
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vascular graft infection by Staphylococcus aureus: efficacy of cefazolin, teicoplanin and vancomycin prophylaxis protocols in a rat model.
    Atahan E; Gul M; Ergun Y; Eroglu E
    Eur J Vasc Endovasc Surg; 2007 Aug; 34(2):182-7. PubMed ID: 17481929
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Accuracy of drug infusion pumps under computer control.
    Connor SB; Quill TJ; Jacobs JR
    IEEE Trans Biomed Eng; 1992 Sep; 39(9):980-2. PubMed ID: 1473827
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The delivery of drugs to patients by continuous intravenous infusion: modeling predicts potential dose fluctuations depending on flow rates and infusion system dead volume.
    Lovich MA; Kinnealley ME; Sims NM; Peterfreund RA
    Anesth Analg; 2006 Apr; 102(4):1147-53. PubMed ID: 16551914
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of pretreatment with 0.9% sodium chloride or insulin solutions on the delivery of insulin from an infusion system.
    Furberg H; Jensen AK; Salbu B
    Am J Hosp Pharm; 1986 Sep; 43(9):2209-13. PubMed ID: 3766574
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stability of vancomycin hydrochloride in various concentrations of dextrose injection.
    Nahata MC; Miller MA; Durrell DE
    Am J Hosp Pharm; 1987 Apr; 44(4):802-4. PubMed ID: 3578315
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of cefazolin and vancomycin on osteoblasts in vitro.
    Edin ML; Miclau T; Lester GE; Lindsey RW; Dahners LE
    Clin Orthop Relat Res; 1996 Dec; (333):245-51. PubMed ID: 8981903
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An in vivo-in vitro study of cefepime and cefazolin dialytic clearance during high-flux hemodialysis.
    Maynor LM; Carl DE; Matzke GR; Gehr TW; Farthing C; Farthing D; Brophy DF
    Pharmacotherapy; 2008 Aug; 28(8):977-83. PubMed ID: 18657014
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Delivery of gentamicin by a controlled-release infusion system versus a minibag system.
    Munoz DM; Green ER; Chrymko MM; Mylotte JM; Kitrenos JG
    Clin Pharm; 1988 Apr; 7(4):303-7. PubMed ID: 3365924
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of a biodegradable antibiotic delivery system.
    Lin SS; Ueng SW; Liu SJ; Chan EC; Chao EK; Tsai CH; Chen KT; Wei FC; Shih CH
    Clin Orthop Relat Res; 1999 May; (362):240-50. PubMed ID: 10335303
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of bead size and polymerization in PMMA bone cement on vancomycin release.
    Shinsako K; Okui Y; Matsuda Y; Kunimasa J; Otsuka M
    Biomed Mater Eng; 2008; 18(6):377-85. PubMed ID: 19197114
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vivo accuracy of gravity-flow i.v. infusion systems.
    Crass RE; Vance JR
    Am J Hosp Pharm; 1985 Feb; 42(2):328-31. PubMed ID: 3976679
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stability of cefazolin sodium and metronidazole at 8 degrees C for use as an i.v. admixture.
    Rivers TE; McBride HA; Trang JM
    J Parenter Sci Technol; 1993; 47(3):135-7. PubMed ID: 8360806
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.